fr   en
Agreements
Select a partner :
Type of agreement :





Select a compound/Disease :
Choose date:
[<<]      «      54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64      »      [65]
Date Partners Compound / Disease area / Development phase Type of agreement Nature / Financial terms
2007-02-05 MediVas (USA)
Wyeth (USA)
recombinant clotting factors / Haemophilia R&D
manufacturing
commercialization/ distribution
See details
2007-02-02 Galapagos (Belgium)/Hillcrest Therapeutics (USA)
 
The PPAR-delta programme (peroxisome proliferator-activated receptor)
The programme comes out of the UK firm Inpharmatica, acquired by Galapagos in December 2006. / diabetes, obesity
commercialization/ distribution
development
See details
2007-02-01 Cobra Biomanufacturing (UK)/Pharmexa (Denmark)
protein vaccine PX107 / Bone disorders manufacturing
See details
2007-02-01  
Bayer Healthcare (Germany)/CSL Behring (Australia)
Kogenate®/Helixate® (recombinant factor VIII) /   commercialization/ distribution
See details
2007-01-31 Palatin Technologies (USA)
AstraZeneca (UK)
compounds targeting melanocortin receptors / obesity R&D
licensing
commercialization/ distribution
See details
2007-01-31 Argenta Discovery (UK)
AstraZeneca (UK)
improved bronchodilatators / chronic obstructive pulmonary disease (COPD) R&D
See details
2007-01-31 Crucell (The Netherlands)
Abbott (USA)
STAR technology /   licensing
See details
2007-01-30 DebioPharm (Switzerland)/Kirin Brewery (Japan)
 
Debio-719 (inhibitor of cell signalling via lysophosphatidic acid, which plays a role in tumour formation and metastasis progression). / cancer development
See details
2007-01-30 Siena Biotech (Italy)
Cenix Bioscience (Germany)
novel therapeutic target / unspecified neurodegenerative disease R&D
See details
2007-01-30 Compugen (Israel)
Teva Pharmaceutical (Israel)
renal toxicity markers /   R&D
See details
2007-01-25 Tigenix (Belgium)
Fidia Advanced Biopolymers (Italy)
biological implants for cartilage regeneration (combination of ChondroCelect® and Hyalograft® C, hyaluronan-based biocompatible and biodegradable scaffold that was the first 3-dimensional cell culture matrix specifically developed for use in cartilage repair)
/ repair of damaged and osteoarthritic joints
commercialization/ distribution
development
See details
2007-01-24 Avontec (Germany)/Activaero (Germany)
 
AVT-01
(double-strand oligonucleotide, a specific inhibitor of a transcription factor involved in the regulation of chronic inflammation - STAT-1) / asthma
development
See details
2007-01-19 BioInvent (Sweden)/Genentech (USA)
 
BI-204 / Cardiovascular disease commercialization/ distribution
development
See details
2007-01-17 Archemix (USA)
Merck KGaA (Germany)
aptamers (synthetic single-strand nucleic acids) / cancer R&D
commercialization/ distribution
See details
2007-01-16 Crucell (The Netherlands)
Novo Nordisk (Denmark)
STAR technology for the production of monoclonal antibodies /   licensing
See details
[<<]      «      54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64      »      [65]